Possible sarcopenia, sarcopenic obesity phenotypes and their association with diabetes: Evidence from LASI wave-1 (2017-18).

Aims: To assess the prevalence of possible sarcopenia and sarcopenic obesity phenotypes and investigate their association with self-reported diabetes among community-dwelling individuals aged 45 or above.

Methods: Utilizing data from 62,899 individuals in LASI wave-1 (2017-18), the assessment of possible sarcopenia was done on two critical parameters: muscle (handgrip) strength and physical performance (gait speed), following the 2019 guidelines from the Asian working group on sarcopenia (AWGS). BMI, WC, WHR, and WHtR defined sarcopenic obesity phenotypes.

Microbes mediated alleviation of chromium (Cr VI) stress for improved phytoextraction in fodder maize ( L.) cultivar.

This study investigates the potential of chromium (VI) resistant bacterial isolates to alleviate heavy metal stress in fodder maize plants and enhance phytoremediation. Twenty-one bacterial strains were isolated from contaminated water, with five strains; (BHR1) (BHR2), (BHR4), (BHR5) and (BHR6) selected based on their significant plant-growth promoting (PGP) traits and heavy metal tolerance. Under chromium (Cr VI) stress, the BHR1 strain significantly improved seed germination, seedling length and vigor index of fodder maize variety (J 1007) especially at 150 mg/L Cr (VI), where these parameters increased by 3.

Understanding LC/MS-Based Metabolomics: A Detailed Reference for Natural Product Analysis.

Liquid chromatography, when used in conjunction with mass spectrometry (LC/MS), is a powerful tool for conducting accurate and reproducible investigations of numerous metabolites in natural products (NPs). LC/MS has gained prominence in metabolomic research due to its high throughput, the availability of multiple ionization techniques and its ability to provide comprehensive metabolite coverage. This unique method can significantly influence various scientific domains.

Cryobiological aspects of upscaling cryopreservation for encapsulated liver cell therapies.

For the efficient delivery of a cell therapy a treatment must be provided rapidly, at clinical scale, contain a sufficient active cellular component (biomass), and adhere to a multitude of regulatory requirements. Cryopreservation permits many of these demands to be met more readily. Here we present the cryopreservation and recovery of large volume (2.